Combined Use of cyclinD1 and Ki67 for Prognosis of Luminal-Like Breast Cancer Patients

BACKGROUND: Ki67 is a biomarker of proliferation to be used in immunohistochemistry (IHC)-based surrogate assay to determine the necessity of cytotoxic therapy for Luminal-like breast cancer patients. cyclinD1 is another frequently used biomarker of proliferation. A retrospective study was performed...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Junmei, Zhang, Wenfeng, Lyu, Yan, Zou, Jiarui, Zhang, Yunyun, Lyu, Jiahong, Zhang, Jianbo, Xie, Shuishan, Zhang, Cuiping, Zhang, Jiandi, Tang, Fangrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630735/
https://www.ncbi.nlm.nih.gov/pubmed/34858818
http://dx.doi.org/10.3389/fonc.2021.737794

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630735/
https://www.ncbi.nlm.nih.gov/pubmed/34858818
http://dx.doi.org/10.3389/fonc.2021.737794

Ejemplares similares